Ultraviolet radiation and the anterior eye

Eye and Contact Lens

Volumn 37, Issue 4, 2011, Pages 214-224

  Coroneo, Minas ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cataract; Contact lens; Dysphotopsia; Eye; Ocular surface squamous neoplasia; Pterygium; Sun protection; Sunglasses; Ultraviolet

Indexed keywords

CYCLOSPORIN; GELATINASE A; GELATINASE B; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR ALPHA;

CATARACT; CONTACT LENS; DIET; EYE PROTECTION; EYELID; FLUORESCENCE; GLAUCOMA; HUMAN; LENS; NICOTINIC ACID DEFICIENCY; OPHTHALMOLOGY; PATHOGENESIS; PELLAGRA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; PUBLIC HEALTH; RADIATION EXPOSURE; RETINA; REVIEW; SIGNAL TRANSDUCTION; SOLAR RADIATION; SPECTACLES; ULTRAVIOLET RADIATION; UVEA; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY;

ANIMALS; ANTERIOR EYE SEGMENT; ENVIRONMENTAL EXPOSURE; HUMANS; PREVALENCE; PTERYGIUM; PUBLIC HEALTH; ULTRAVIOLET RAYS; WORLD HEALTH;

EID: 79960016915     PISSN: 15422321     EISSN: 1542233X     Source Type: Journal    
DOI: 10.1097/ICL.0b013e318223394e     Document Type: Review

References (134)

1. Coroneo MT. Albedo concentration in the anterior eye and the ophthalmohelioses. Master of Surgery Thesis, University of N.S.W, 1992.
2. CoroneoMT, Müller-StolzenburgNW, HoA. Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg 1991;22:705-711.
3. Welch RP. A Familiar Treatise on Diseases of the Eye. Sydney, Australia, T. Trood, 1840.
4. Gye C. The Cockney and the Crocodile. London, United Kingdom, Faberand Faber, 1962.
5. Kerkenezov N. A ptergium survey of the far north coast of New South Wales. Trans Ophthalmol Soc Aust 1956;16:110-119.
6. Lancaster HO. Some geographical aspects of the mortality from melanoma in Europeans. Med J Aust 1956;43:1082-1087.
7. Cameron M. Pterygium Throughout the World. Springfield, IL, Charles C Thomas, 1965.
8. Urbach F. Geographic pathology of skin cancer. In: Urbach F, ed. The Biologic Effects of Ultraviolet Radiation. Oxford, Pergamon, 1969, pp 635-650.
9. Norn MS. Prevalence of pinguecula in Greenland and in Copenhagen, and its relation to pterygium and spheroid degeneration. Acta Ophthalmol (Copenh) 1979;57:96-105. (Pubitemid 9083240)
10. Norn MS. Spheroidal degeneration, keratopathy, pinguecula, and pterygiumin Japan (Kyoto).Acta Ophthal Scand 1984;62:54-60.
11. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: The blue mountains eye study. Aust N Z J Ophthalmol 1998; 26(suppl 1):S2-S5. (Pubitemid 28298818)
12. Wittenberg S. Solar radiation and the eye: A review of knowledge relevant to eye care. Am J Optom Physiol Optics 1986;63:676-689. (Pubitemid 17171835)
13. Sliney DH. Geometrical assessment of ocular exposure to environmental UV radiation-Implications for ophthalmic epidemiology. J Epidemiol 1999;9(suppl 6):S22-S32.
14. Evans T.A new operation for pterygium. Transactions of the Third Session, Intercolonial Medical Congress of Australasia, Sydney, Australia, 1892. Charles Potter Govt Printer, 1893.
15. D'Ombrain A. The surgical treatment of pterygium. Br J Ophthalmol 1948; 32:65-71.
16. Saad RS. Pterygium, pinguecula and visual acuity. Aust J Ophthal 1977;5:52-66.
17. Jensen OL. Pterygium, the dominant eye and the habit of closing one eye in sunlight. Acta Ophthalmol (Copenh) 1982;60:568-574. (Pubitemid 12046952)
18. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: A positive, correlation. Br J Ophthalmol 1984;68:343-346. (Pubitemid 15118324)
19. Symons MJ. Some remarks on pterygium. The Australasian Medical Gazette. 1888;7:162-164.
20. National Trachoma and Eye Health Program. Sydney, Australia, Royal Australian College of Ophthalmologists, 1980.
21. Dawson CR, Juster R, Marx R, et al. Limbal disease in trachoma and other ocular chlamydial infections: Risk factors for corneal vascularisation. Eye 1989;3:204-209. (Pubitemid 20018563)
22. Ben-Amer MI. Pterygium in a Libyan village. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1989;66:63-71.
23. Butler G. On Australian ophthalmia. Lancet 1894;64:415.
24. Kobayashi H, Kohshima S. Unique morphology of the human eye and its adaptive meaning: Comparative studies on external morphology of the primate eye. J Hum Evol 2001;40:419-435. (Pubitemid 32526496)
25. Kobayashi H, Kohshima S. Unique morphology of the human eye. Nature 1997;387:767-768. (Pubitemid 27270891)
26. Favilla I. Ocular effects of ultraviolet radiation. In: Health Effects of Ozone Layer Depletion. Canberra, Australia, Australian Government Publishing Service, 1989, pp 96-113.
27. Davinger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 1971;229:560-561.
28. Coroneo MT. Albedo concentration in the anterior eye: A phenomenon that locates some solar diseases. Ophthalmic Surg 1990;21:60-66. (Pubitemid 20115726)
29. Coroneo MT, Muller-Stolzenburg NW, Ho A. Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg 1991;22: 705-711.
30. Coroneo MT. Pterygium as an early indicator of ultraviolet insolation: A hypothesis. Br J Ophthalmol 1993;77:734-739. (Pubitemid 23326063)
31. Maloof AJ, Ho A, Coroneo MT. Influence of corneal shape on limbal light focusing. Invest Ophthalmol Vis Sci 1994;35:2592-2598. (Pubitemid 24137057)
32. Kwok LS, Kuznetsov VA, Ho A, et al. Prevention of the adverse photic effects of peripheral light-focusing using UV-blocking contact lenses. Invest Ophthalmol Vis Sci 2003;44:1501-1507. (Pubitemid 36378574)
33. Kwok LS, Daszynski DC, Kuznetsov VA, et al. Peripheral light focusing as a potential mechanism for phakic dysphotopsia and lens phototoxicity. Ophthalmic Physiol Opt 2004;24:119-129. (Pubitemid 41711031)
34. von Helmoltz H. Treatise on physiological optics. In: Southall JPC, ed. Mechanism of Accommodation. Vols. 1 and 12. 3rd ed. New York, NY, Dover Publications, 1962, pp 143-172.
35. Graves B. Diseases of the cornea. In: Berens C, ed. The Eye and its Diseases, Chapter XXV. Philadelphia, PA, WB Saunders, 1936, pp 443-557.
36. Mackevicius L. Pterygium. Probable etiology due to persistent photothermal microtrauma. Arch Oftalmol B Aires 1968;43:126-130.
37. Rizzuti AB. Diagnostic illumination test for keratoconus. Am J Ophthalmol 1970;70:141-143.
38. Taylor RL, Hanks MA. Developmental changes in precursor lesions of bovine ocular carcinoma. Vet Med Small Anim Clin 1972;67:669-671.
39. Arenas E. Etiopatologia de la pinguecula y el pterigio. Pal Oftal Panam 1978 2:28-31.
40. Diponegoro RMA, Mulock-HowerAW. A statistical contribution to the study of the aetiology of pterygium. Folia Ophthalmol Orient 1936;2:195-210.
41. Detels R, Dhir SP. Pterygium: A geographical study. Arch Ophthalmol 1967;78:485-491.
42. Dolezalova V. Is the occurrence of a temporal pterygium really so rare? Ophthalmologica 1977;174:88-91. (Pubitemid 8066317)
43. Wu K, He M, Xu J, et al. Pterygium in aged population in Doumen County, China. Yan Ke Xue Bao 2002;18:181-184.
44. Handmann M. Ueber den Beginn des altersstares in der unterenlinsenhalfte. Klinischstatistische Studien an 845 Augen mit Cataracta senilis incipiens nebst Bemerkungen über die Cataracta glaukomatosa und diabetica. Klin Montsbl Augenheilkd 1909;47:692-720.
45. Hoover HL. Solar ultraviolet irradiation of the human cornea, lens, and retina: Equations of ocular irradiation. Appl Optics 1986;25:359-368. (Pubitemid 16147186)
46. Podskochy A. Protective role of corneal epithelium against ultraviolet radiation damage. Acta Ophthalmol Scand 2004;82:714-717. (Pubitemid 40057782)
47. Mootha VV, Pingree M, Jaramillo J. Pterygia with deep corneal changes. Cornea 2004;23:635-638. (Pubitemid 38988707)
48. Chui J, Di Girolamo N, Coroneo MT. The role of substance P in the pathogenesis of pterygia. Invest Ophthalmol Vis Sci 2007;48:4482-4489. (Pubitemid 351260963)
49. MaloofAJ, Ho A, Coroneo MT. Anterior segment peripheral light concentration and the crystalline lens. Invest Ophthalmol Vis Sci 1994;35,1327. Abstract 332.
50. Duke-Elder S, MacFaul PA. Radiational injuries. In: System of Ophthalmology. Injuries, Part 2, Non-Mechanical Injuries. Vol. XIV. London, United Kingdom, Henry Kimpton, 1972, pp 837-1010.
51. Rochtchina E, Mitchell P, Coroneo M, et al. Lower nasal distribution of cortical cataract: The blue mountains eye study. Clin Exper Ophthalmol 2001;29:111-115. (Pubitemid 32618969)
52. Abraham AG, Cox C, West S. The differential effect of ultraviolet light exposure on cataract rate across regions of the lens. Invest Ophthalmol Vis Sci 2010;51:3919-3923.
53. Lofgren S, Ayala M, Kakar M, et al. UVR cataract after regional in vitro lens exposure. Invest Ophthalmol Vis Sci 2002;43. E-Abstract 3577.
54. Coroneo MT, Pham T, Kwok LS. Off-axis edge glare in pseudophakic dysphotopsia. J Cataract Refract Surg 2003;29:1969-1973. (Pubitemid 37385966)
55. Coroneo M. Consultation section. J Cataract Refract Surg 2005;31:652-653.
56. Coroneo MT. Consultation section. Cataract surgical problem. Consultation response. J Cataract Refract Surg 2011;37:424-425.
57. Kwok LS, Coroneo MT. A model for pterygium formation. Cornea 1994; 13:219-224. (Pubitemid 24129155)
58. Kwok LS, Coroneo MT. Temporal and spatial growth patterns in the normal and cataractous human lens. Exp Eye Res 2000;71:317-322.
59. Liu S, Li J, Tan DT, et al. The eyelid margin: A transitional zone for 2 epithelial phenotypes. Arch Ophthalmol 2007;125:523-532. (Pubitemid 46596725)
60. Lindgren G, Diffey BL, Larko O. Basal cell carcinoma of the eyelids and solar ultraviolet radiation exposure. Br J Ophthalmol 1998;82:1412-1415. (Pubitemid 28556527)
61. Taylor HR, West S, Muñoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol 1992;110:99-104.
62. Chui J, Coroneo MT, Tat LT, et al. Ophthalmic pterygium: A stem cell disorder with premalignant features. Am J Pathol 2011;178:817-827.
63. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999;10:282-288. (Pubitemid 30339430)
64. Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: Role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004;23:195-228. (Pubitemid 38496401)
65. Chui J, Coroneo MT. Pterygium pathogenesis, actinic damage, and recurrence. Chapter 1. In: Hovanesian J, ed. Pterygium: Techniques and Technologies for Surgical Success. Thorofare, NJ, Slack, in press.
66. Chui J, Di Girolamo N, Wakefield D, et al. The pathogenesis of pterygium: Current concepts and their therapeutic implications. Ocul Surf 2008;26-47.
67. Di Girolamo N, Tedla N, Kumar RK, et al. Culture and characterization of epithelial cells from human pterygia. Br J Ophthalmol 1999;83: 1077-1082. (Pubitemid 29433434)
68. Kato N, Shimmura S, Kawakita T, et al. Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci 2007;48:1511-1517. (Pubitemid 351261333)
69. Di Girolamo N, McCluskey P, Lloyd A, et al. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci 2000;41:671-679. (Pubitemid 30158875)
70. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci 2000;41:4142-4149.
71. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: Potential role in angiogenesis. Invest Ophthalmol Vis Sci 2001;42:1963-1968. (Pubitemid 32726025)
72. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci 2003;44:4705-4714. (Pubitemid 37315282)
73. Di Girolamo N, Coroneo M, Wakefield D. Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol 2005;167: 489-503. (Pubitemid 43026104)
74. Di Girolamo N, Kumar RK, Coroneo MT, et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3430-3437. (Pubitemid 35334350)
75. Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006;47:2430-2437. (Pubitemid 351639824)
76. Yang SF, Lin CY, Yang PY, et al. Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C. Invest Ophthalmol Vis Sci 2009;50:4588-4589.
77. Seo MJ, Kim JM, Lee MJ, et al. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. Curr Eye Res 2010;35:165-175.
78. Li M, Zhang M, Lin Y, et al. Tear function and goblet cell density after pterygium excision. Eye 2007;21:224-228. (Pubitemid 46454602)
79. Yalcin Tok O, Burcu Nurozler A, Ergun G, et al. Topical cyclosporine A in the prevention of pterygium recurrence. Ophthalmologica 2008;222:391-396.
80. Gitter BD, Waters DC, Threlkeld PG, et al. Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist. Eur J Pharmacol 1995;289: 439-446.
81. Nolan TM, DiGirolamo N, Sachdev NH, et al. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol 2003;162:567-574. (Pubitemid 36267863)
82. Liu Z, Xie Y, Zhang M. Overexpression of type I growth factor receptors in pterygium. Chin Med J (Engl) 2002;115:418-421.
83. Sachdev NH, Di Girolamo N, Nolan TM, et al. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: Implications for cortical cataract formation. Invest Ophthalmol Vis Sci 2004;45:4075-4082. (Pubitemid 39411163)
84. Sachdev NH, Di Girolamo N, McCluskey PJ, et al. Lens dislocation in Marfan syndrome: Potential role of matrix metalloproteinases in fibrillin degradation. Arch Ophthalmol 2002;120:833-835. (Pubitemid 34620367)
85. Sachdev N, Wakefield D, Coroneo MT. Lens dislocation in Marfan syndrome and UV-B light exposure. Arch Ophthalmol 2003;121:585. (Pubitemid 36427655)
86. Ng J, Coroneo MT, Wakefield D, et al. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia. Invest Ophthalmol Vis Sci 2008;49:5295-5306.
87. Skippen B, Tsang HH, Assaad NN, et al. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alpha-2b. Arch Ophthalmol 2010;128:1368-1369.
88. Hollows FC. Ultraviolet radiation and eye diseases. Trans Menzies Foundation 1989;15:113-117.
89. Sinclair C, Foley P. Skin cancer prevention in Australia. Br J Dermatol 2009:161(suppl 3):116-123.
90. Lee GA, Hirst LW, Sheehan M. Knowledge of sunlight effects on the eyes and protective behaviors in adolescents. Ophthalmic Epidemiol 1999;6: 171-180. (Pubitemid 29500448)
91. Livingston PM, White V, Hayman J, et al. Sun exposure and sun protection behaviours among Australian adolescents: Trends over time. Prev Med 2003;37:577-584. (Pubitemid 37443497)
92. Livingston PM, White V, Hayman J, et al. Australian adolescents' sun protection behavior: Who are we kidding? 20070604 DCOM-20070802.
93. Ooi JL, Sharma NS, Papalkar D, et al. Ultraviolet fluorescence photography to detect early sun damage in the eyes of school-aged children. Am J Ophthalmol 2006;141:294-298. (Pubitemid 43188029)
94. Ooi JL, Sharma NS, Sharma S, et al. Ultraviolet fluorescence photography: Patterns in established pterygia. Am J Ophthalmol 2007;143:97-101.
95. Krengel S. Wearing sunglasses a risk factor for the development of cutaneous malignant melanoma? Int J Dermatol 2002;41:191-192. (Pubitemid 34601120)
96. Threlfall TJ. Sunglasses and clothing-An unhealthy correlation? Aust J Public Health 1992;16:92-196.
97. Hedblom EE. Snowscape eye protection. Development of a sunglass for useful vision with comfort from antarctic snowblindness, glare, and calorophthalgia. Arch Environ Health 1961;2:685-704.
98. Deaver DM, Davis J, Sliney DH. Vertical visual fields-of-view in outdoor daylight. Lasers Light Ophthalmol 1996;7:121-125.
99. Sliney DH. Photoprotection of the eye-UV radiation and sunglasses. J Photochem Photobiol B 2001;64:166-175.
100. Morris A, Temme LA, Hamilton PV. Visual acuity of the U.S. Navy jet pilot and the use of the helmet sun visor. Aviat Space Environ Med 1991;62: 715-721.
101. Dille JR, Marano JA. The effects of spectacle frames on field of vision. Aviat Space Environ Med 1984;55:957-959. (Pubitemid 14012167)
102. Steel SE, Mackie SW, Walsh G. Visual field defects due to spectacle frames: Their prediction and relationship to UK driving standards. Ophthalmic Physiol Opt 1996;16:95-100. (Pubitemid 26085912)
103. ISO DIS 12312-1 Eye and face protection-Sunglasses and related eyewear-Part 1: Sunglasses for general use. 2010.
104. Rosenthal FS, Bakalian AE, Lou CQ, et al. The effect of sunglasses on ocular exposure to ultraviolet radiation. Am J Public Health 1988;78:72-74. (Pubitemid 18030017)
105. Hickson-Curran SB, Nason RJ, Becherer PD, et al. Clinical evaluation of ACUVUE contact lenses with UV blocking characteristics. Optom Vis Sci 1997;74:632-638. (Pubitemid 27432772)
106. Giasson CJ, Quesnel NM, Boisjoly H. The ABCs of ultraviolet-blocking contact lenses: An ocular panacea for ozone loss? Int Ophthalmol Clin 2005;45:117-139. (Pubitemid 40194361)
107. Walsh JE, Bergmanson JP, Saldana G Jr, et al. Can UV radiation-blocking soft contact lenses attenuate UV radiation to safe levels during summer months in the southern United States? Eye Contact Lens 2003;29(suppl 1): S174-S179; discussion S190-S191, S192-S194. Erratum in: Eye Contact Lens 2003;29:135.
108. Walsh JE, Bergmanson JP,Wallace D, et al. Quantification of the ultraviolet radiation (UVR) field in the human eye in vivo using novel instrumentation and the potential benefits of UVR blocking hydrogel contact lens. Br J Ophthalmol 2001;85:1080-1085. (Pubitemid 32835395)
109. Bergmanson JP, Pitts DG, Chu LW. The efficacy of a UV-blocking soft contact lens in protecting cornea against UV radiation. Acta Ophthalmol (Copenh) 1987;65:279-286. (Pubitemid 17096058)
110. Bergmanson JP, Pitts DG, Chu LW. Protection from harmful UV radiation by contact lenses. J Am Optom Assoc 1988;59:178-182.
111. Bergmanson JP, Walsh JE, Harmey J. UV Overdose vs hyperoxia. Eye Contact Lens 2005;31:95. (Pubitemid 43197024)
112. Sasaki K, Sasaki H, Honda R, et al. High prevalence of pterygium in the population of a tropical area in China-Sanya eye study. Invest Opthalmol Vis Sci 2007;48:E-5292.
113. Beard HH, Dimitry JT. Some observations upon the chemical nature of the pterygium. Am J Ophthal 1945;28:303-305.
114. Ascher KW, Anderson JR. A pterygium map. Acta XVII Conc Ophthal 1954;3:1640-1641. Discussion.
115. Coroneo MT, Coroneo H. Feast Your Eyes: The Eye Health Cookbook. West Lakes, S. Australia, Seaview Press, 2010. ISBN 9781740085618.
116. Detopoulou P, Panagiotakos DB, Antonopoulou S, et al. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: The ATTICA study. Am J Clin Nutr 2008;87: 424-430. (Pubitemid 351226080)
117. Zeisel SH. Is there a new component of the Mediterranean diet that reduces inflammation? Am J Clin Nutr 2008;87:277-278. (Pubitemid 351226060)
118. Fortes C,Mastroeni S,Melchi F, et al.A protective effect of the Mediterranean diet for cutaneous melanoma. Int J Epidemiol 2008;37:1018-1029.
119. Shapira N. Nutritional approach to sun protection: A suggested complement to external strategies. 2010;68:75-86.
120. Wong A. Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol 2008;23:609-614.
121. Black HS, Rhodes LE. The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer. Cancer Detect Prev 2006;30: 224-232. (Pubitemid 44163058)
122. Jackson MJ, Jackson MJ, McArdle F, et al. Effects of micronutrient supplements on UV-induced skin damage. Proc Nutr Soc 2002;61:187-189. (Pubitemid 34665792)
123. Black HS, Rhodes LE. The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer. Cancer Detect Prev 2006;30: 224-232. (Pubitemid 44163058)
124. Kune GA, Bannerman S, Field B, et al. Diet, alcohol, smoking, serum betacarotene, and vitamin A in male nonmelanocytic skin cancer patients and controls. Nutr Cancer 1992;18:237-244. (Pubitemid 23015568)
125. Mason RS, Sequeira VB, Dixon KM, et al. Photoprotection by 1alpha, 25- dihdroxyvitamin D and analogs: Further studies on mechanisms and implications for UV-damage. J Steroid Biochem Mol Biol 2010;121:164-168.
126. Dowd DR, MacDonald PN. The 1, 25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin. J Steroid Biochem Mol Biol 2010;121: 317-321.
127. Goyal JL, Rao VA, Srinivasan R, et al. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994;78:295-297. (Pubitemid 24114172)
128. MacKenzie F, Hirst LW, Hilton A. Pterygia and retinitis pigmentosa. Aust N Z J Ophthalmol 1994;22:145-146. (Pubitemid 24270351)
129. Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008;87:S1080-S1086.
130. Hume EM, Lucas NS, Smith HH. On the absorption of vitamin D from the skin. Biochem J 1927;21:362-367.
131. Wolpowitz D, Gilchrest BA. The vitamin D questions: How much do you need an how should you get it? J Am Acad Dermatol 2006;54:301-317. (Pubitemid 43144400)
132. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632.
133. McGrath JJ, Kimlin MG, Saha SM, et al. Vitamin D insufficiency in southeast Queensland. Med J Aust 2001;174:150-151.
134. Diehl JW, Chiu MW. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther 2010;23:48-60.